BioSpace News Archive

Antengene Corporation Limited, a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncology, would like to providean update on the state of its business operations and other recent developments.

The two US-based board members of Nordic Nanovector ASA, Joanna Horobin and Jean-Pierre Bizzari have resolved to settle a total number of 22,860 RSUs that were issued to them in June 2020 after they had elected to receive all or part of their remuneration for the period from the annual general meeting in 2020 to the annual general meeting in 2021 in RSUs.

The increasing cases of urea cycle disorder is a key factor augmenting the growth of the global urea cycle disorders treatment market during the forecast period, set between 2020 and 2030.

Acellular dermal matrices have gained popularity in implant-based breast procedures, most notably in aesthetic breast reconstructions.

The telerehabilitation system is for patients who live far from actual centers of rehabilitation.

The single-use bioprocessing probes and sensors market may harness promising growth across the assessment period of 2019-2029.

The global molecular spectroscopy market is expected to observe promising growth across the assessment period of 2020-2030.

Hemophilia is an inherited bleeding disorder which prevents blood clotting. People born with hemophilia have little or no clotting factor.

An extensive variety of medicinal services associations and establishments are receiving healthcare workforce managements systems so as to defeat administration issues.

The DNA enclosed in the cell makes up our genome. Genomics is basically a study of sequence of letters in the DNA and how each thread transfers information to help cells in the body system to work properly.